Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-8-15
|
pubmed:abstractText |
The present study has demonstrated: (1) glibenclamide can reduce resting tension in canine cerebral arteries but has no effect on resting tension in the rat aorta; (2) glibenclamide can relax prostaglandin F2 alpha-induced contractions in the rat aorta, and in canine femoral, mesenteric, renal, coronary, basilar and middle cerebral arteries; (3) the relaxation produced by glibenclamide in rat aorta is comparable to that of glyceryl trinitrate and stronger than that of papaverine; (4) canine femoral arteries are less sensitive to glibenclamide than the other arteries; (5) in cerebral arteries glibenclamide was as effective as papaverine, but less effective than glyceryl trinitrate; (6) the actions of glibenclamide on cerebral arteries are not mediated by cGMP as they were not blocked by methylene blue, an inhibitor of guanylate cyclase; (7) the effects of glibenclamide are not endothelium-dependent. The mechanism by which glibenclamide produces relaxation is not clear; while the drug is known to block ATP-dependent potassium channels, in vascular smooth muscle this would cause contraction, not dilation. The action of glibenclamide may be at the level of the receptor or the signal transduction process.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
195
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
27-35
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1906005-Animals,
pubmed-meshheading:1906005-Arteries,
pubmed-meshheading:1906005-Dinoprost,
pubmed-meshheading:1906005-Dogs,
pubmed-meshheading:1906005-Endothelium, Vascular,
pubmed-meshheading:1906005-Female,
pubmed-meshheading:1906005-Glyburide,
pubmed-meshheading:1906005-Male,
pubmed-meshheading:1906005-Muscle, Smooth, Vascular,
pubmed-meshheading:1906005-Muscle Contraction,
pubmed-meshheading:1906005-Rats,
pubmed-meshheading:1906005-Signal Transduction
|
pubmed:year |
1991
|
pubmed:articleTitle |
Glibenclamide relaxes vascular smooth muscle constriction produced by prostaglandin F2 alpha.
|
pubmed:affiliation |
Department of Surgery, University of Alberta, Edmonton, Canada.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|